| [1] |
YIN Xiaoyu, DONG Liping, XIAO Fengli, .
Upadacitinib for ankylosing spondylitis complicated with secukinumab-associated atopic dermatitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(9): 656-659.
|
| [2] |
GENG Darui, GUI Ke, LIU Yixuan, CHEN Ziyan, TIAN Xin, LIU Yumei.
Kaposi's sarcoma misdiagnosed as atopic dermatitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(9): 663-665.
|
| [3] |
PU Qianhan, ZHENG Chen, ZOU Ailing.
Dupilumab for the treatment of atopic dermatitis complicated with twenty-nail dystrophy: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(8): 599-601.
|
| [4] |
GAO Mingxuan, WU Juan, WANG Yang, ZHAO Jiahui.
Research progress on CARD11 mutations and regulatory T cell dysfunction in atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(7): 536-541.
|
| [5] |
WU Mengwei, LIU Peize, LI Haoyuan, CHEN Hanxiang, ZHI Lili.
Dupilumab-associated ocular surface disease complicated with HSV-1 and Staphylococcus aureus infection: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(6): 450-452.
|
| [6] |
MEI Yajie, SU Fei, CHEN Hui, JIANG Min.
Real-world efficacy and safety of abrocitinib in elderly patients with moderate-to-severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 344-347.
|
| [7] |
WAN Guijun, LI Jingyi.
Role of transient receptor potential channels in the pruritus of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 382-388.
|
| [8] |
XIA Pu, MO Ran, CHEN Zhiming, YANG Yong.
A case of atopic dermatitis associated with CARD11 variant
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 152-157.
|
| [9] |
SHAO Yuling, WANG Na.
Successful treatment of dupilumab-associated nail psoriasis with upadacitinib: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 206-210.
|
| [10] |
YANG Chenchen, CHEN Ping, ZHOU Qian, XU Xihuan, LI Xia.
Clinical efficacy of dupilumab in infants with moderate-to-severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(10): 716-721.
|
| [11] |
CHENG Anqi, LI Jianwei, WANG Yuning, ZHENG Rongtao, LI Zhen, LIU Hong.
Down syndrome with atopic dermatitis and acanthosis nigricans: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(10): 731-734.
|
| [12] |
FAN Hengheng, GENG Yun, XIONG Yuyun, LI Yumei.
New progress in circadian rhythm regulation in atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(10): 750-754.
|
| [13] |
BI Zhixia, HAN Jindou.
Dupilumab versus abrocitinib in the treatment of atopic dermatitis: a meta-analysis of efficacy and safety
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 5-10.
|
| [14] |
BAI Fan, YU Wanlong, XU Yabo, FAN Lifang, LIU Yuyuan, TIAN Zan, LEI Mingjun.
Efficacy of abrocitinib in the treatment of moderate-to-severe prurigo phenotype atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 593-597.
|
| [15] |
SUN Yaru, ZHANG Yisheng, CHEN Yao, CHEN Jinbo, CHEN Liuqing.
Identification of novel therapeutic targets for atopic dermatitis based on genome-wide associationstudies and proteomic colocalization analysis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(12): 869-875.
|